Skip to main content
. 2018 Jun 15;57(12):1741–1745. doi: 10.2169/internalmedicine.0027-17

Figure 4.

Figure 4.

The clinical course. Growth hormone, testosterone, thyroid hormone and corticosteroid replacement therapy were re-started. The serum AST and ALT levels gradually decreased, and the platelet count increased to 16-20×104/μL.